Ardena's new Aseptic Fill-Finish Plant in Ghent receives GMP license

Sygnature Discovery appoints new industry leaders to their board of directors

I'm getting in touch with the latest news from Sygnature Discovery, a world-leading contract research organization. The company has recently appointed two industry leaders, Vanessa Malier and Martin LeBlanc, to their board of directors, reinforcing its commitment to innovation and strategic leadership. With decades of experience and a wealth of expertise in their respective fields, both Martin and Vanessa bring unique and valuable perspectives to Sygnature Discovery's board. Further details can be found in the press release below. I have also attached headshots of both Vanessa and Martin to this email. Please let me know if you have any questions or if you require any further information. Many thanks, Charlotte

CD Genomics Launches Full-Length 16S/18S/ITS Amplicon Sequencing Service

CD Genomics Unveils Cutting-Edge 5mC/5hmC Sequencing Service to Drive Epigenomics Research Forward

Hovione expands nasal drug delivery capabilities with the development of nasal powder delivery device technology in collaboration with IDC

Ventric Health Named Best Digital/Mobile Health Solution in the Fierce Healthcare Innovation Awards 2023 for Its Vivio System™

Ventric Health Named Best Digital/Mobile Health Solution in the Fierce Healthcare Innovation Awards 2023 for Its Vivio System™

CD Genomics Takes Genomic Research to New Heights with Ribo-seq Technology

"Prescribing the Future: 503A U.S. Compounding Pharmacies Market Soars to $7.18 Billion by 2032, Fueled by Surging Demand for Personalized Healthcare"

The 503A U.S. compounding pharmacies market is not just witnessing growth; it's shaping the future of personalized healthcare. As demand intensifies, regulatory challenges persist, and innovative solutions emerge, these pharmacies stand at the intersection of patient-centric care and technological advancement, promising a transformative journey ahead.

Improving the Patient Experience With AI-Powered Medication History That Helps Streamline Admissions at Southlake Regional Health Centre

DrFirst Healthcare Innovations has partnered with Southlake Regional Health Centre

Exothera’s CTO Patrick Thiaville nominated as a member of Alliance for mRNA Medicines Board

Exothera has announced its Nucleic Acids Chief Technology Officer, Patrick Thiaville has been nominated as a member of the Alliance for mRNA Medicines (AMM) board.

InsightRX Brings Groundbreaking Advancements in Model-Informed Precision Dosing to the ASHP Midyear Conference

InsightRX Brings Groundbreaking Advancements in Model-Informed Precision Dosing to the ASHP Midyear Conference

Northern Virginia Technology Council Recognizes DrFirst as a Top Tech Leader for Fourth Consecutive Year

Northern Virginia Technology Council Recognizes DrFirst as a Top Tech Leader for Fourth Consecutive Year

Profacgen Updates Its Fermentation Process Development Solutions

Creative BioMart Unveils Comprehensive Lectin Portfolio for Diverse Research Applications

Matexcel Enlarged Its Offerings for Bioglass Products

Lifeasible Enhanced Its Plant Metabolite Profiling Services

Creative Enzymes Unveils Cutting-edge Homocysteine Methyltransferase, Recombinant for Enhanced Bioprocessing

Creative Enzymes Introduces S-Adenosyl-L-Homocysteine Hydrolase, Recombinant

IntegrateRNA Unveils Revolutionary Self-Amplifying RNA In Vitro Synthesis Service

Creative Proteomics Unleashes the Exosome Untargeted Metabolomics Service